IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC s two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in .
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), the company focused on delivering imaging platforms to treat patients more effectively, said it is making progress across.
/PRNewswire/ ConcertAI s TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.